Skip to content
Apex Nursing

Guide — Respiratory

COPD vs Asthma for Nurses

Both COPD and asthma cause obstructive airway disease, but their underlying causes, clinical presentations, reversibility, and treatment priorities are fundamentally different. Distinguishing them is essential for safe nursing care.

10 min read · Respiratory

Educational use only. Clinical diagnosis requires provider evaluation, spirometry, and clinical context. This guide supports NCLEX preparation and learning — it does not replace clinical assessment or medical decision-making. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.

Pathophysiology

COPD

Chronic Obstructive Pulmonary Disease is an umbrella term for chronic bronchitis (persistent airway inflammation, excess mucus production) and emphysema (destruction of alveolar walls, loss of elastic recoil). COPD involves:

  • Irreversible airflow obstruction — permanent structural lung damage
  • Air trapping from loss of elastic recoil → hyperinflation, barrel chest
  • V/Q mismatch → chronic hypoxemia ± CO₂ retention (Type II respiratory failure pattern)
  • Primary cause: cigarette smoking (90% of cases); environmental exposures
Asthma

Asthma is a chronic inflammatory airway disease characterized by reversible bronchospasm. Key features:

  • Episodic, triggered bronchoconstriction — airway narrows during attacks, opens between attacks
  • IgE-mediated or non-allergic airway hyperreactivity → mast cell degranulation → bronchospasm + mucus
  • Airflow obstruction is reversible (with bronchodilators or spontaneously)
  • Primary causes: allergens, exercise, cold air, infections, aspirin/NSAIDs, stress

Clinical Presentation

FeatureCOPDAsthma
OnsetGradual, usually >40 years oldOften in childhood or early adulthood
Symptoms between attacksPersistent dyspnea, chronic cough, sputumOften asymptomatic or mild between episodes
PatternProgressive decline, daily symptomsEpisodic, triggered attacks
CoughChronic, productive (esp. morning)Episodic, may be dry or productive
SputumChronic sputum productionMay produce thick mucus during attacks
DyspneaProgressive on exertion → restEpisodic, often nocturnal or early morning
Chest shapeBarrel chest (hyperinflation)Usually normal between attacks
Smoking historyAlmost always presentNot required; worsens control

Assessment Findings

FindingCOPDAsthma
Breath soundsDistant; prolonged expiration; may have rhonchiExpiratory wheezes; reduced air entry in severe attack
PercussionHyperresonant (air trapping)Normal between attacks; hyperresonant during attack
Accessory musclesChronic use with exacerbationsDuring acute attacks; normal between
SpO₂ target88–92% (avoid O₂-driven hypercapnia)94–98% (normal target)
ABG patternMay have compensated resp. acidosis (chronic CO₂ retention)Resp. alkalosis early; normal or alkalosis between attacks
Pursed-lip breathingCommon (maintains auto-PEEP, slows expiration)Not typical

Treatment Differences

Oxygen Therapy
COPDTitrate to SpO₂ 88–92%. High-flow oxygen may suppress hypoxic drive in chronic CO₂ retainers — use Venturi mask for precise FiO₂ delivery. Avoid over-oxygenating.
AsthmaTitrate to SpO₂ 94–98%. Higher flow oxygen is generally safe in acute attacks. Monitor for improvement.
Bronchodilators
COPDShort-acting beta-agonists (SABA) for acute relief; long-acting beta-agonists (LABA) and anticholinergics (tiotropium) for maintenance. Combination inhalers are standard.
AsthmaSABAs (albuterol) are first-line for acute attacks. Inhaled corticosteroids (ICS) are the cornerstone of long-term control. Step-up therapy based on severity.
Corticosteroids
COPDSystemic steroids (prednisone, methylprednisolone) for acute exacerbations — reduce inflammation and shorten recovery. ICS only in certain high-risk phenotypes.
AsthmaICS are the primary long-term controller medication. Systemic steroids used for moderate to severe exacerbations.
Non-Invasive Ventilation
COPDBiPAP (NPPV) is first-line for acute exacerbations with respiratory acidosis — reduces intubation rates significantly.
AsthmaLess commonly used; heliox and magnesium sulfate may help in severe refractory attacks before intubation.

Nursing Considerations

For Both Conditions
  • Monitor SpO₂ and respiratory rate continuously during exacerbations
  • Position upright (high-Fowler's) to maximize lung expansion and reduce work of breathing
  • Administer bronchodilators as ordered; reassess breath sounds before and after
  • Encourage pursed-lip breathing (COPD) and controlled breathing techniques
  • Teach proper inhaler technique — MDI, spacer use, and timing of SABA vs controller medications
COPD-Specific
  • Target SpO₂ 88–92% — avoid over-oxygenation in chronic CO₂ retainers
  • Recognize early signs of exacerbation: increased dyspnea, change in sputum color/quantity
  • Smoking cessation is the single most important intervention to slow COPD progression
Asthma-Specific
  • Identify and avoid triggers (allergens, exercise, NSAIDs, cold air)
  • Silent chest (absent wheeze) in severe asthma = airflow is so reduced the wheeze disappears — this is an emergency sign
  • Teach action plan: when to use rescue inhaler, when to seek emergency care

NCLEX Pearls

  • COPD = irreversible obstruction. Asthma = reversible bronchospasm. This is the key distinction.
  • SpO₂ target for COPD is 88–92%. For asthma, 94–98%. Do not over-oxygenate COPD patients.
  • Pursed-lip breathing is a natural COPD compensation — it creates auto-PEEP to keep airways open during exhalation.
  • Barrel chest (AP:lateral ratio approaching 1:1) = chronic air trapping in COPD.
  • Silent chest in an acute asthma attack = near-complete airway obstruction = immediate provider notification.
  • BiPAP (NPPV) is first-line for COPD exacerbation with acute respiratory acidosis — reduces intubation rate.
  • ICS are the cornerstone of asthma long-term control. SABAs are rescue; ICS are prevention.

Related Resources

Standards & sources

Fact-checked Jun 21, 2026

This page is written to align with American Association for Respiratory Care (AARC) · GOLD (COPD) / ATS / CHEST. It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →